Assessment of a pharmacist-driven point-of-care spirometry clinic within a primary care physicians office
Authors:
- R. PacittiRPR. Pacitti
- W. WarningWWW. Warning
Open Access
- 1 December 2011
- journal article
- Published by SciELO Espana/Repisalud in Pharmacy Practice
- Vol. 9 (4) , 221-227
Abstract
To assess value-added service of a pharmacist-driven point-of-care spirometry clinic to quantify respiratory disease abnormalities within a primary care physicians office. This retrospective, cohort study was an analysis of physician referred patients who attended our spirometry clinic during 2008-2010 due to pulmonary symptoms or disease. After spirometry testing, data was collected retrospectively to include patient demographics, spirometry results, and pulmonary pharmaceutical interventions. Abnormal spirometry was identified as an obstructive and/or restrictive defect. Sixty-five patients with a primary diagnosis of cough, shortness of breath, or diagnosis of asthma or chronic obstructive pulmonary disease were referred to the spirometry clinic for evaluation. A total of 51 (32 patients with normal spirometry, 19 abnormal spirometry) completed their scheduled appointment. Calculated lung age was lower in normal spirometry (58.1; SD=20 yrs) than abnormal spirometry (78.2; SD=7.5 yrs, p<0.001). Smoking pack years was also lower in normal spirometry (14.4; SD=10.7 yrs) than abnormal spirometry (32.7; SD=19.5 yrs, p=0.004). Resting oxygen saturation of the arterial blood (SaO2) was higher in normal spirometry than abnormal spirometry (98.1% vs 96.5%, p=0.016). Mean change in the forced expiratory volume in one second (FEV1) after administration of bronchodilator was greater in patients with abnormal spirometry compared with normal spirometry (10.9% vs 4.1%, p<0.001). Spirometry testing assisted in addition, discontinuation or altering pulmonary drug regimens in 41/51 patients (80%) and the need for further diagnostic testing or physician referral in 14/51 patients (27.4%). Implementation of a pharmacist-driven spirometry clinic is a value-added service that can be integrated with other clinical pharmacy services within the ambulatory care setting. Further studies are needed to determine the role of pharmacists in performing spirometry testing and measuring performance outcomes of the pulmonary patient.Keywords
This publication has 22 references indexed in Scilit:
- Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnnals of Internal Medicine, 2011
- White paper on expanding the role of pharmacists in chronic obstructive pulmonary diseaseJournal of the American Pharmacists Association, 2011
- Medication therapy management and condition care services in a community-based employer settingAmerican Journal of Health-System Pharmacy, 2010
- Management of chronic obstructive pulmonary disease by pharmacists in an internal medicine departmentAmerican Journal of Health-System Pharmacy, 2009
- Effectiveness of pharmacist intervention for asthma control improvementEuropean Respiratory Journal, 2007
- Spirometry in the Primary Care SettingChest, 2005
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEuropean Respiratory Journal, 2004
- Respiratory function testing: The impact of respiratory scientists on the training and support of primary health care providersRespirology, 2004
- Pulmonary Function Testing: Coding and Billing IssuesRespiratory Care, 2003
- Pulmonary-Function TestingNew England Journal of Medicine, 1994